Ethiopia Declares End to Marburg Outbreak with No Cases Reported
The epidemic, initially detected November 14, 2025, within the South Ethiopia Region, produced 14 laboratory-confirmed Marburg infections—resulting in nine fatalities and five survivors—alongside five additional probable deaths, according to a WHO statement.
WHO reported collaborating with Ethiopia's Health Ministry and the Ethiopian Public Health Institute to orchestrate a unified response spanning four impacted districts: Jinka, Malle, and Arba Minch in the South Ethiopia Region, plus Hawassa in the Sidama Region.
The organization deployed 36 specialists and reassigned 28 personnel within 24 hours of outbreak confirmation to strengthen government-led operations in affected zones.
During the epidemic, authorities monitored 857 contacts over 21-day periods, WHO stated. Three healthcare professionals contracted the virus, with two succumbing to the disease.
WHO credited Ethiopia's effectiveness to previous public health infrastructure investments, encompassing strengthened laboratory capabilities, disease monitoring networks, specialized personnel training, and coordination via the Public Health Emergency Operations Center.
Marburg represents a rare yet lethal pathogen comparable to Ebola, triggering fever, vomiting, diarrhea, and hemorrhaging. No approved vaccine or targeted therapy currently exists.
The Ethiopian outbreak followed similar emergencies across African nations including Angola, Guinea, Rwanda, Uganda, and Tanzania.
Legal Disclaimer:
MENAFN provides the
information “as is” without warranty of any kind. We do not accept
any responsibility or liability for the accuracy, content, images,
videos, licenses, completeness, legality, or reliability of the information
contained in this article. If you have any complaints or copyright
issues related to this article, kindly contact the provider above.
Legal Disclaimer:
EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.
